Using ice cream to combat side effects of chemo
Key points
- New Zealand scientists are developing an ice cream that is so good for you, it could come with a doctor's prescription.
- Researchers at the University of Auckland are working with dairy giant Fonterra to create a "medical dessert" which has shown encouraging signs in combating the side effects of chemotherapy in cancer sufferers.
- The ice cream, called ReCharge, is using active ingredients from dairy products to relieve diarrhoea, anemia and lack of appetite in people undergoing chemotherapy.
- Participants in a trial have been eating a 100 gram tub of the strawberry-flavoured ice cream each day.
New Zealand scientists are developing an ice cream that is so good for you, it could come with a doctor's prescription.
Researchers at the University of Auckland are working with dairy giant Fonterra to create a "medical dessert" which has shown encouraging signs in combating the side effects of chemotherapy in cancer sufferers.
The ice cream, called ReCharge, is using active ingredients from dairy products to relieve diarrhoea, anemia and lack of appetite in people undergoing chemotherapy.
Participants in a trial have been eating a 100 gram tub of the strawberry-flavoured ice cream each day.
"The two bio-active milk components developed for ReCharge have the unique potential to assist the body in coping with the side effects of chemotherapy," Fonterra's chief technology office Jeremy Hill said in a statement.
--
WELLINGTON (Reuters Life!)
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsLaser may reduce prostate surgery's sexual side effects
One of the challenges of prostate cancer surgery is removing the cancer-affected gland without side effects. The procedure is estimated to cause long-term sexual dysfunction in half of men. Now, new published research…
7 August 2010
NewsBreast Cancer Prevention: Raloxifene as Effective as Tamoxifen with Fewer Side Effects
In an update of the 19,490-patient Study of Tamoxifen and Raloxifene (STAR) P-2 trial in breast cancer prevention, both raloxifene and tamoxifen remain effective options to prevent breast cancer at 81 months of…
20 April 2010
NewsLong-term testicular cancer survivors at high risk for neurological side effects
Long-term survivors of testicular cancer who were treated with cisplatin-based chemotherapy had more severe side effects, including neurological side effects and Raynaud-like phenomena, than men who were not treated…
